獣医循環器学の世界市場レポート 2025年

獣医循環器学市場規模は、今後数年間で力強い成長が見込まれます。2029年には年間平均成長率（CAGR）8.8％で43億5,000万米ドルに成長します。予測期間の成長は、獣医循環器学調査への投資の増加、遠隔診察のための遠隔医療サービスの拡大、ペットの飼育率の伸び、専門的な獣医療に対する消費者の需要の高まり、高度な獣医循環器学トレーニングプログラムの利用可能性の増加などに起因しています。予測期間における主な動向としては、クラウド・セキュリティ・ソリューション、統合コラボレーション・プラットフォーム、データプライバシーとコンプライアンス重視の強化、マルチクラウド環境への移行の加速、拡張性と柔軟性の高いクラウド・インフラストラクチャ・ソリューションの開発などが挙げられます。

ペットや家畜における心臓疾患の発生率の増加が、今後の獣医循環器学市場の成長を促進すると予想されます。動物のこれらの心臓疾患は、心臓の構造や機能に影響を与え、血液循環の悪化、心臓効率の低下、健康合併症の可能性をもたらします。ペットや家畜の心臓病増加の要因としては、寿命の延長、肥満、栄養不良、遺伝的要因、日常的な獣医療の不足などが挙げられます。さらに、環境ストレス要因や生活環境の変化も、これらの動物の心臓血管疾患の発生を高めている可能性があります。獣医循環器学は、ペットや家畜の心臓病の診断、治療、管理において重要な役割を担っており、専門的なケア、高度な画像技術、低侵襲手術などの革新的な手技を駆使して、心臓の健康と生活の質全体を向上させています。例えば、2024年3月に米国獣医師会が報告したように、粘液腫性僧帽弁変性症（MMVD）は北米で犬が罹患する最も一般的な心臓病であり、犬の心臓疾患全体の75％を占めています。13歳の小型犬の85％が粘液腫性僧帽弁病変の徴候を示すが、これは必ずしも臨床的意義を示すものではないとされています。僧帽弁閉鎖不全症では犬の心臓関連の死亡率は40％から70％と推定されます。従って、ペットや家畜の心臓病有病率の増加は、獣医循環器学市場の拡大を促進することになります。

獣医循環器学分野の主要企業は、心臓疾患の治療を強化し、手術結果を改善し、より良い回復と生活の質のために低侵襲な選択肢を提供するために、経カテーテル的端から端までの僧帽弁修復術（TEER）などの技術的進歩に注力しています。TEERは、弁機能を改善し心臓の負担を軽減するためにクランプを用いて僧帽弁の漏れに対処する侵襲性の低い手技です。例えば、2023年2月、英国に拠点を置く動物病院紹介センターであるウィローズ動物病院は、犬で最も一般的な心臓疾患である粘液腫性僧帽弁膜症（MMVD）の犬に対する新しい心臓治療を導入しました。この治療法は、人間における従来の手術に代わる有力な選択肢と考えられており、犬においても初期の臨床結果が有望視されています。全身麻酔をかけ、胸壁を少し切開し、連続X線と経食道超音波を使って心臓の尖端まで針を誘導し、僧帽弁にVクランプを正確に設置して漏れを減らします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界獣医循環器学 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の獣医循環器学市場：成長率分析
• 世界の獣医循環器学市場の実績：規模と成長, 2019-2024
• 世界の獣医循環器学市場の予測：規模と成長, 2024-2029, 2034F
• 世界獣医循環器学総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の獣医循環器学市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品
• 診断
• 世界の獣医循環器学市場：適応症別、実績と予測, 2019-2024, 2024-2029F, 2034F
• うっ血性心不全
• 心筋疾患
• 不整脈
• その他の適応症
• 世界の獣医循環器学市場動物の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンパニオンアニマル
• 生産動物
• 世界の獣医循環器学市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 動物病院
• クリニック
• その他のエンドユーザー
• 世界の獣医循環器学市場医薬品の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 降圧剤
• 利尿剤
• 抗不整脈薬
• ベータ遮断薬
• ACE阻害薬
• カルシウムチャネル遮断薬
• 陽性変力薬
• 心臓の健康のための栄養補助食品
• 世界の獣医循環器学市場、診断のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 心電図（ECG）
• 心エコー検査装置
• ホルターモニター
• 血圧モニター
• 心臓バイオマーカー検査
• 胸部X線検査
• 超音波装置
• 心臓モニタリングのための遠隔医療ソリューション

第7章 地域別・国別分析

• 世界の獣医循環器学市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の獣医循環器学市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 獣医循環器学市場：競合情勢
• 獣医循環器学市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Royal Canin
• IDEXX Laboratories Inc.
• Ceva Sante Animale S.A.
• Fujifilm Healthcare Solutions
• Dechra Pharmaceuticals PLC
• Vetoquinol S.A.
• ESAOTE S.p.A.
• SonoScape Medical Corp.
• Jurox Pty Limited
• Eickemeyer Veterinary Equipment GmbH
• VetriScience Laboratories Inc.
• Bionet America Inc.
• Scil Animal Care Company
• Woodley Equipment Company Ltd.
• Universal Imaging Corporation

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 獣医循環器学市場2029：新たな機会を提供する国
• 獣医循環器学市場2029：新たな機会を提供するセグメント
• 獣医循環器学市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Veterinary cardiology is a specialized field of veterinary medicine dedicated to diagnosing and managing heart diseases in animals. This branch ranges from routine examinations to advanced treatments, aiming to enhance pets' quality of life by providing targeted diagnosis and treatment for heart conditions, which leads to better health outcomes and longer lifespans.

The primary product types in veterinary cardiology are pharmaceuticals and diagnostics. Pharmaceuticals refer to the medications used to treat heart conditions in animals, such as managing heart failure, arrhythmias, and other cardiovascular issues. Indications for these medications include congestive heart failure, myocardial disease, arrhythmias, and other heart conditions affecting companion animals and production animals. The end users of these products include veterinary hospitals, clinics, and other related facilities.

The veterinary cardiology market research report is one of a series of new reports from the business research company that provides veterinary cardiology market statistics, including veterinary cardiology industry global market size, regional shares, competitors with an veterinary cardiology market share, detailed veterinary cardiology market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary cardiology industry. This veterinary cardiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary cardiology market size has grown strongly in recent years. It will grow from $2.84 billion in 2024 to $3.1 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth in the historic period can be attributed to increasing pet ownership, growing awareness of pet health, rising prevalence of cardiac disorders in animals, expansion of veterinary specialty clinics, and the increasing availability and affordability of pet insurance.

The veterinary cardiology market size is expected to see strong growth in the next few years. It will grow to $4.35 billion in 2029 at a compound annual growth rate (CAGR) of 8.8%. The growth in the forecast period can be attributed to increasing investment in veterinary cardiology research, expansion of telemedicine services for remote consultations, growth in pet adoption rates, rising consumer demand for specialized veterinary care, and the increasing availability of advanced veterinary cardiology training programs. Major trends in the forecast period include cloud security solutions, integrated collaboration platforms, enhanced focus on data privacy and compliance, accelerated migration to multi-cloud environments, and the development of more scalable and flexible cloud infrastructure solutions.

The increasing incidence of heart diseases in both pets and livestock is anticipated to drive growth in the veterinary cardiology market in the future. These heart conditions in animals impact the heart's structure and functionality, resulting in compromised blood circulation, diminished cardiac efficiency, and possible health complications. Contributing factors to the rise in heart diseases among pets and livestock include longer lifespans, obesity, poor nutrition, genetic factors, and insufficient routine veterinary care. Moreover, environmental stressors and changes in living conditions may also heighten the occurrence of cardiovascular diseases in these animals. Veterinary cardiology plays a crucial role in diagnosing, treating, and managing heart diseases in pets and livestock, utilizing specialized care, advanced imaging techniques, and innovative procedures such as minimally invasive surgeries to enhance heart health and overall quality of life. For example, as reported by the American Veterinary Medical Association in March 2024, Myxomatous mitral valve degeneration (MMVD) is the most common heart disease affecting dogs in North America, accounting for 75% of all canine cardiac conditions. It is noted that 85% of small dogs aged 13 years exhibit signs of a myxomatous mitral valve lesion, although this does not always indicate clinical significance. In MMVD cases, the estimated rate of cardiac-related fatalities in dogs ranges from 40% to 70%. Consequently, the growing prevalence of heart diseases in pets and livestock is set to propel the veterinary cardiology market's expansion.

Leading companies in the veterinary cardiology sector are focusing on technological advancements such as transcatheter edge-to-edge mitral valve repair (TEER) to enhance the treatment of heart diseases, improve surgical outcomes, and provide minimally invasive options for better recovery and quality of life. TEER is a less invasive procedure that addresses mitral valve leakage by using a clamp to improve valve function and reduce heart strain. For instance, in February 2023, Willows Veterinary Centre, a veterinary referral center based in the UK, introduced a novel heart treatment for dogs with myxomatous mitral valve disease (MMVD), the most common heart condition in dogs. This procedure, which is considered a viable alternative to traditional surgery in humans, has shown promising early clinical results in dogs. It involves general anesthesia and a minor chest wall incision, with a needle guided to the heart's apex using continuous X-rays and transesophageal ultrasound to precisely place a V-clamp across the mitral valve to reduce leakage.

In October 2023, EQT AB, a Swedish investment organization, acquired VetPartners for $940 million. This acquisition aligns with EQT's strategy to expand its investment in the animal health sector, aiming to enhance veterinary services and meet the growing demand for animal healthcare. VetPartners, based in the UK, is a veterinary group that offers comprehensive cardiology care and services for animals.

Major companies operating in the veterinary cardiology market are Merck & Co. Inc., Medtronic plc, Siemens Healthineers AG, Zoetis Inc., Boehringer Ingelheim Animal Health, Royal Canin, IDEXX Laboratories Inc., Ceva Sante Animale S.A., Fujifilm Healthcare Solutions, Dechra Pharmaceuticals PLC, Vetoquinol S.A., ESAOTE S.p.A., SonoScape Medical Corp., Jurox Pty Limited, Eickemeyer Veterinary Equipment GmbH, VetriScience Laboratories Inc., Bionet America Inc., Scil Animal Care Company, Woodley Equipment Company Ltd., Universal Imaging Corporation, VetBlue Inc., TeleVet

North America was the largest region in the veterinary cardiology market in 2024. The regions covered in the veterinary cardiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the veterinary cardiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The veterinary cardiology market consists of revenues earned by entities by providing services such as educational services, emergency care, telemedicine services, follow-up care, and consultations. The market value includes the value of related goods sold by the service provider or included within the service offering. veterinary cardiology market also includes sales of monitoring devices, treatment products, supportive products, and surgical products. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Cardiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary cardiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for veterinary cardiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The veterinary cardiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Pharmaceuticals; Diagnostics
• 2) By Indication: Congestive Heart Failure; Myocardial (Heart Muscle) Disease; Arrhythmias; Other Indications
• 3) By Animal Type: Companion Animals; Production Animals
• 4) By End-User: Veterinary Hospitals; Clinics; Other End Users
• Subsegments:
• 1) By Pharmaceuticals: Antihypertensives; Diuretics; Antiarrhythmic Drugs; Beta Blockers; ACE Inhibitors; Calcium Channel Blockers; Positive Inotropes; Nutraceuticals For Cardiac Health
• 2) By Diagnostics: Electrocardiograms (ECG); Echocardiography Devices; Holter Monitors; Blood Pressure Monitors; Cardiac Biomarker Tests; Thoracic Radiography; Ultrasound Devices; Telemedicine Solutions for Cardiac Monitoring
• Companies Mentioned: Merck & Co. Inc.; Medtronic plc; Siemens Healthineers AG; Zoetis Inc.; Boehringer Ingelheim Animal Health
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Veterinary Cardiology Market Characteristics

3. Veterinary Cardiology Market Trends And Strategies

4. Veterinary Cardiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Veterinary Cardiology Growth Analysis And Strategic Analysis Framework

• 5.1. Global Veterinary Cardiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Veterinary Cardiology Market Growth Rate Analysis
• 5.4. Global Veterinary Cardiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Veterinary Cardiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Veterinary Cardiology Total Addressable Market (TAM)

6. Veterinary Cardiology Market Segmentation

• 6.1. Global Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceuticals
• Diagnostics
• 6.2. Global Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Congestive Heart Failure
• Myocardial (Heart Muscle) Disease
• Arrhythmias
• Other Indications
• 6.3. Global Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Companion Animals
• Production Animals
• 6.4. Global Veterinary Cardiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Veterinary Hospitals
• Clinics
• Other End Users
• 6.5. Global Veterinary Cardiology Market, Sub-Segmentation Of Pharmaceuticals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antihypertensives
• Diuretics
• Antiarrhythmic Drugs
• Beta Blockers
• ACE Inhibitors
• Calcium Channel Blockers
• Positive Inotropes
• Nutraceuticals For Cardiac Health
• 6.6. Global Veterinary Cardiology Market, Sub-Segmentation Of Diagnostics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Electrocardiograms (ECG)
• Echocardiography Devices
• Holter Monitors
• Blood Pressure Monitors
• Cardiac Biomarker Tests
• Thoracic Radiography
• Ultrasound Devices
• Telemedicine Solutions for Cardiac Monitoring

7. Veterinary Cardiology Market Regional And Country Analysis

• 7.1. Global Veterinary Cardiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Veterinary Cardiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Veterinary Cardiology Market

• 8.1. Asia-Pacific Veterinary Cardiology Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Veterinary Cardiology Market

• 9.1. China Veterinary Cardiology Market Overview
• 9.2. China Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Veterinary Cardiology Market

• 10.1. India Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Veterinary Cardiology Market

• 11.1. Japan Veterinary Cardiology Market Overview
• 11.2. Japan Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Veterinary Cardiology Market

• 12.1. Australia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Veterinary Cardiology Market

• 13.1. Indonesia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Veterinary Cardiology Market

• 14.1. South Korea Veterinary Cardiology Market Overview
• 14.2. South Korea Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Veterinary Cardiology Market

• 15.1. Western Europe Veterinary Cardiology Market Overview
• 15.2. Western Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Veterinary Cardiology Market

• 16.1. UK Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Veterinary Cardiology Market

• 17.1. Germany Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Veterinary Cardiology Market

• 18.1. France Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Veterinary Cardiology Market

• 19.1. Italy Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Veterinary Cardiology Market

• 20.1. Spain Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Veterinary Cardiology Market

• 21.1. Eastern Europe Veterinary Cardiology Market Overview
• 21.2. Eastern Europe Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Veterinary Cardiology Market

• 22.1. Russia Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Veterinary Cardiology Market

• 23.1. North America Veterinary Cardiology Market Overview
• 23.2. North America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Veterinary Cardiology Market

• 24.1. USA Veterinary Cardiology Market Overview
• 24.2. USA Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Veterinary Cardiology Market

• 25.1. Canada Veterinary Cardiology Market Overview
• 25.2. Canada Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Veterinary Cardiology Market

• 26.1. South America Veterinary Cardiology Market Overview
• 26.2. South America Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Veterinary Cardiology Market

• 27.1. Brazil Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Veterinary Cardiology Market

• 28.1. Middle East Veterinary Cardiology Market Overview
• 28.2. Middle East Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Veterinary Cardiology Market

• 29.1. Africa Veterinary Cardiology Market Overview
• 29.2. Africa Veterinary Cardiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Veterinary Cardiology Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Veterinary Cardiology Market, Segmentation By Animal Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Veterinary Cardiology Market Competitive Landscape And Company Profiles

• 30.1. Veterinary Cardiology Market Competitive Landscape
• 30.2. Veterinary Cardiology Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Veterinary Cardiology Market Other Major And Innovative Companies

• 31.1. Royal Canin
• 31.2. IDEXX Laboratories Inc.
• 31.3. Ceva Sante Animale S.A.
• 31.4. Fujifilm Healthcare Solutions
• 31.5. Dechra Pharmaceuticals PLC
• 31.6. Vetoquinol S.A.
• 31.7. ESAOTE S.p.A.
• 31.8. SonoScape Medical Corp.
• 31.9. Jurox Pty Limited
• 31.10. Eickemeyer Veterinary Equipment GmbH
• 31.11. VetriScience Laboratories Inc.
• 31.12. Bionet America Inc.
• 31.13. Scil Animal Care Company
• 31.14. Woodley Equipment Company Ltd.
• 31.15. Universal Imaging Corporation

32. Global Veterinary Cardiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Cardiology Market

34. Recent Developments In The Veterinary Cardiology Market

35. Veterinary Cardiology Market High Potential Countries, Segments and Strategies

• 35.1 Veterinary Cardiology Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Veterinary Cardiology Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Veterinary Cardiology Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250423_r33611_Veterinary_Cardiology_GMR_2025